Papers matching “Life Events Questionnaire” 20
Not finding it? Sign in to also search OpenAlex live.
-
Quality of life and functional recovery after venous stent placement for postthrombotic syndrome: insights from the ARIVA multinational randomized trial2026 Research and Practice in Thrombosis and Haemostasis article Health Professions Central Venous Catheters and Hemodialysis Open access
Stefano Barco, Simon Wolf, Tim Sebastian, Riccardo Mario Fumagalli, Evy Micieli, Christian Erbel, +4 more
0citations -
Assessment of efficacy and safety of endoscopic lung volume reduction with one-way valves in patients with a very low FEV12023 ERJ Open Research article Medicine Chronic Obstructive Pulmonary Disease (COPD) Research Open access
Thomas Sgarbossa, Pavlina Lenga, Franz Stanzel, Angélique Holland, Christian Grah, Wolfgang Gesierich, +10 more
12citations -
Early integration of palliative care versus standard cardiac care for patients with heart failure (EPCHF): a multicentre, parallel, two-arm, open-label, randomised controlled trial2024 The Lancet Healthy Longevity article Medicine Heart Failure Treatment and Management Open access
Mahmoud Balata, Lukas Radbruch, Michaela Hesse, Ralf Westenfeld, Martin Neukirchen, Roman Pfister, +9 more
14citations -
Treatment Free Remission after Nilotinib Plus Peg-Interferon Alpha Induction and Peg-Interferon Alpha Maintenance Therapy for Newly Diagnosed Chronic Myeloid Leukemia Patients; The Tiger Trial
Andreas Hochhaus, Andreas Burchert, Susanne Saußele, Gabriela Maria Baerlocher, Jiřı́ Mayer, Tim H. Brümmendorf, +21 more
21citations -
Transcranial Direct Current Stimulation of the Temporoparietal Junction in Autism Spectrum Disorder: Results of a Phase‐IIa Randomized, Double‐Blind, Sham‐Controlled Feasibility Study
Christina Luckhardt, Magdalena Schütz, Andreas M. Mühlherr, Sara Boxhoorn, Christine Ecker, Hannah Mössinger, +13 more
5citations -
ASC4START: A Phase IIIb, Open-Label, Randomized Study of Tolerability and Efficacy of Asciminib Versus Nilotinib in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia in Chronic Phase
Andreas Hochhaus, Susanne Saußele, François‐Xavier Mahon, Virginia Pilipovic, Yifan Zhang, Peter Schuld, +1 more
1citations -
S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.
Andreas Hochhaus, Andreas Burchert, Susanne Saußele, Gabriela Maria Baerlocher, Jiřı́ Mayer, Tim H. Brümmendorf, +20 more
6citations -
Patient-Reported Outcomes: Danicopan As Add-on Therapy to Ravulizumab or Eculizumab Versus Placebo in Patients with Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis2023 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Caroline Irene Piatek, Jong Wook Lee, Morag Griffin, Jun‐ichi Nishimura, Christopher Jordan Patriquin, Hubert Schrezenmeier, +9 more
0citations -
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study
Viktor Grünwald, Annika Karch, Markus Kajo Schuler, Patrick Schöffski, Hans‐Georg Kopp, Sebastian Bauer, +11 more
91citations -
Sustainability in Neurointervention—Results from an Exploratory International Cross-sectional Online Survey Among Peers2026 Clinical Neuroradiology article Environmental Science Climate Change and Health Impacts Open access
Johannes Alex Rolf Pfaff, Johanna Ospel, Katharina Pfaff, Kazutaka Uchida, Gregor J. Kasprian, Petra Cimflová, +5 more
0citations
20 results